1. The Defendant (Counterclaim Plaintiff) paid KRW 74,554,616 to the Plaintiff (Counterclaim Defendant) and its related amount from May 25, 2012 to December 12, 2014.

1. The principal lawsuit and counterclaim shall also be deemed to exist;

A. The parties concerned are medical corporations that operate the Busan High Hospital (hereinafter “Defendant Hospital”). The plaintiff is a patient who passed an operation at the Defendant Hospital, who was admitted to the hospital.

B. (1) On May 21, 2012, the Plaintiff’s treatment was conducted on May 21, 2012, and on May 25, 2012, 2012, the Plaintiff complained of the Plaintiff’s symptoms and ridge lives, etc., and applied to the Defendant hospital to the Defendant hospital. The Plaintiff was diagnosed of spine lives lives lives lives lives lives lives lives lives lives lives lives at the Defendant hospital, and

(2) After the surgery, the Plaintiff continuously appealed to the left side of the bridge, to the extent that the Plaintiff, after the surgery, constantly complained of the dysium and pain, and to the dysium.

Meanwhile, during the period from May 25, 2012 to May 27, 2012, the medical professionals of the Defendant Hospital administered 2gg of cell trophical loss (three household cephalspin) twice a day, and 2g of the 1st day from May 28, 2012 to June 1, 2012, the medical professionals of the Defendant Hospital administered 2g (one household cephalpin) two times a day.

(3) On June 6, 2012, the results of the TRI shooting on June 6, 2012, it was observed that the body was accumulated due to the climatic drums from the aftermath of the pressure of the operation, and the accumulation of such climatic drums pressured by the pressure of the operation.

(4) 2012. 6. 8. 감염 발견 및 처치 (가) 2012. 6. 1. 혈액검사 결과 WBC(백혈구, 정상치는 4,500~11,000cell/㎟) 수치가 9,400, CRP(c-reactive protein, 반응성 단백질, 정상치는 0.5mg /dl 이하)가 10이었으나 2012. 6. 8.에는 백혈구 수치가 25,500, CRP 수치가 9.2로 확인되어 피고 병원 의료진은 감염을 의심하게 되었다.

(B) Accordingly, on June 12, 2012, the medical personnel at Defendant Hospital performed an dynasium (aculing operation of dynasium with chlorate) and conducted an fynasium test to verify the bynasium, and on June 16, 2012, the Defendant Hospital selected cynasium, which is an antibiotics responding to bynasiums in response to bynasiums as a result of the fynasium test on June 19, 2012, from June 24, 2012 to June 24, 2012.